Massmutual Trust CO Fsb Provention Bio, Inc. Transaction History

Massmutual Trust CO Fsb

  • $3.48 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022
SELL
$3.65 - $7.3 $8,387 - $16,775
-2,298 Reduced 95.55%
107 $0
Q4 2021

Feb 09, 2022
BUY
$5.59 - $7.39 $7,893 - $10,434
1,412 Added 142.2%
2,405 $14,000
Q2 2021

Aug 16, 2021
BUY
$6.71 - $11.04 $3,677 - $6,049
548 Added 123.15%
993 $8,000
Q4 2020

Feb 16, 2021
BUY
$11.79 - $18.94 $5,246 - $8,428
445 New
445 $8,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email